AMERIPRISE FINANCIAL INC - ADAPTIVE BIOTECHNOLOGIES COR ownership

ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 253 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of ADAPTIVE BIOTECHNOLOGIES COR
ValueSharesWeighting
Q3 2023$433,924
+23.3%
79,619
+51.8%
0.00%
Q2 2023$351,986
-90.7%
52,457
-87.7%
0.00%
-100.0%
Q1 2023$3,778,921
+34.1%
427,964
+16.0%
0.00%0.0%
Q4 2022$2,818,000
-68.7%
368,900
-43.1%
0.00%
-66.7%
Q1 2022$9,000,000
-44.7%
648,479
+11.8%
0.00%
-40.0%
Q4 2021$16,283,000
-17.5%
580,274
-0.0%
0.01%
-16.7%
Q3 2021$19,729,000
-9.4%
580,500
+8.9%
0.01%
-14.3%
Q2 2021$21,782,000
-36.6%
533,082
-37.5%
0.01%
-36.4%
Q1 2021$34,343,000
-23.1%
853,032
+12.9%
0.01%
-31.2%
Q4 2020$44,676,000
+55.3%
755,542
+27.8%
0.02%
+33.3%
Q3 2020$28,760,000
+72.3%
591,408
+71.4%
0.01%
+71.4%
Q2 2020$16,696,000
+80.6%
345,116
+3.7%
0.01%
+40.0%
Q1 2020$9,243,000
+7.7%
332,671
+16.0%
0.01%
+25.0%
Q4 2019$8,582,000
+9.9%
286,858
+13.6%
0.00%
+33.3%
Q3 2019$7,806,000
+0.6%
252,602
+57.3%
0.00%0.0%
Q2 2019$7,756,000160,5970.00%
Other shareholders
ADAPTIVE BIOTECHNOLOGIES COR shareholders Q4 2020
NameSharesValueWeighting ↓
Blue Water Life Science Advisors, LP 2,377,665$12,958,27412.23%
Eagle Health Investments LP 1,214,860$6,620,9871.46%
Matrix Capital Management Company, LP 11,572,590$63,070,6160.76%
Aristotle Atlantic Partners, LLC 3,058,206$16,667,2230.67%
VIKING GLOBAL INVESTORS LP 29,993,708$163,465,7090.66%
Pier Capital, LLC 719,067$3,918,9150.63%
DDD Partners, LLC 783,697$3,385,5710.49%
ARK Investment Management 11,509,308$62,725,7280.48%
Nikko Asset Management Americas, Inc. 6,570,939$35,680,1990.43%
Triatomic Management LP 102,889$560,7450.39%
View complete list of ADAPTIVE BIOTECHNOLOGIES COR shareholders